Drug Discovery Company Metrion Biosciences Closes �2.7M Financing
Aitechpark07 Apr, 2021Technology
Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured ?2.7m in new equity financing, including ?2.25m from lead investor Gresham House Ventures. The funding will be used to expand Metrion?s laboratories in Cambridge, UK, invest in specialist equipment, develop its cell line library, and add GLP cardiac safety services. The financing will also enable the expansion of the Company?s business development activities.
Related Bookmarks
- Sarcos Robotics to Merge with Rotor Acquisition Corp.
- NICE Actimize Introduces AI-Powered SURVEIL-X Suitability
- IDEMIA�s Facial Recognition Ranked #1 in NIST�s Latest FRVT Test
- AKASA�s AI Technology Lead, Byung-Hak Kim, Ph.D., Presents at the Healthcare Natural Language Proces
- Interview with Josh Elliot, Head of Operations at Modzy
- Troubleshoot Common iPad Repair Dubai with Budget
- Get USA Managed VPS Hosting Plans with Flexibility
- Local SEO Services - Contact our Certified Specialists
- How to decide which display advertising platform is right for you?
- Get Best Php Development Services | Hire experienced Developers
Recent Profiles
Muncieyorktownnebo
Corium Skin Clinic
Solitek
Tot88biz
Tip Top Garage Doors
Tsm Signs
Green Gardenia
Clear Title & Escrow
Sodo 66
Hb88